Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Mol Cancer Ther. 2009 Sep 1;8(9):2509–2516. doi: 10.1158/1535-7163.MCT-09-0386

Figure 3.

Figure 3

Combination of triptolide and imatinib enhances death in KBM5 cells. KBM5 cells were treated with triptolide for 24 hours and then plus 1 μM imatinib for an additional 24 hours. Cell death was determined by annexin V staining.